ATE478884T1 - Oligosaccharidderivat - Google Patents

Oligosaccharidderivat

Info

Publication number
ATE478884T1
ATE478884T1 AT04706367T AT04706367T ATE478884T1 AT E478884 T1 ATE478884 T1 AT E478884T1 AT 04706367 T AT04706367 T AT 04706367T AT 04706367 T AT04706367 T AT 04706367T AT E478884 T1 ATE478884 T1 AT E478884T1
Authority
AT
Austria
Prior art keywords
groups
pharmacologically acceptable
oligosaccharide derivative
group
chem
Prior art date
Application number
AT04706367T
Other languages
English (en)
Inventor
Takeshi Honda
Akira Okuno
Masanori Izumi
Xiaoliu Li
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of ATE478884T1 publication Critical patent/ATE478884T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
AT04706367T 2003-01-30 2004-01-29 Oligosaccharidderivat ATE478884T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003022800 2003-01-30
PCT/JP2004/000879 WO2004067542A1 (ja) 2003-01-30 2004-01-29 オリゴ糖誘導体

Publications (1)

Publication Number Publication Date
ATE478884T1 true ATE478884T1 (de) 2010-09-15

Family

ID=32820702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04706367T ATE478884T1 (de) 2003-01-30 2004-01-29 Oligosaccharidderivat

Country Status (21)

Country Link
US (2) US7361744B2 (de)
EP (1) EP1589023B1 (de)
KR (1) KR101050981B1 (de)
CN (2) CN101367851A (de)
AT (1) ATE478884T1 (de)
AU (1) AU2004207726B2 (de)
BR (1) BRPI0406990A (de)
CA (1) CA2514931A1 (de)
DE (1) DE602004028799D1 (de)
DK (1) DK1589023T3 (de)
ES (1) ES2349736T3 (de)
IL (1) IL169577A (de)
MX (1) MXPA05008190A (de)
NO (1) NO20053997L (de)
NZ (1) NZ541455A (de)
PL (1) PL377462A1 (de)
PT (1) PT1589023E (de)
RU (1) RU2290408C2 (de)
TW (1) TWI318202B (de)
WO (1) WO2004067542A1 (de)
ZA (1) ZA200506075B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200612968A (en) * 2004-07-29 2006-05-01 Sankyo Co Oligosaccharide derivatives containing with heterocycle
TW200608967A (en) 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
TW200735880A (en) * 2006-01-27 2007-10-01 Sankyo Co Medicinal compositions for preventing or treating heart failure
GB0614947D0 (en) * 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3785895D1 (de) * 1986-08-13 1993-06-24 Hoechst Ag Oxiran-pseudooligosaccharide, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
JP4643775B2 (ja) * 1999-01-13 2011-03-02 日本食品化工株式会社 香気成分生成阻害剤
JP3909735B2 (ja) * 1999-02-22 2007-04-25 キッコーマン株式会社 マルトオリゴ糖誘導体及びその用途
WO2000050494A1 (en) 1999-02-23 2000-08-31 Ips Corporation Low voc (volatile organic compounds), dimethyl-2-piperidone solvent-based, pvc and cpvc pipe and component adhesives and primers containing minimal or no tetrahydrofuran
JP4373671B2 (ja) 2000-06-06 2009-11-25 キッコーマン株式会社 マルトオリゴ糖誘導体及びその用途

Also Published As

Publication number Publication date
AU2004207726A1 (en) 2004-08-12
EP1589023B1 (de) 2010-08-25
ZA200506075B (en) 2006-05-31
KR101050981B1 (ko) 2011-07-21
RU2290408C2 (ru) 2006-12-27
TW200502204A (en) 2005-01-16
PL377462A1 (pl) 2006-02-06
RU2005124286A (ru) 2006-01-27
CN1768073A (zh) 2006-05-03
AU2004207726B2 (en) 2007-03-15
BRPI0406990A (pt) 2006-01-10
US20060025350A1 (en) 2006-02-02
DK1589023T3 (da) 2010-12-13
US20080194495A1 (en) 2008-08-14
US7361744B2 (en) 2008-04-22
ES2349736T3 (es) 2011-01-11
IL169577A0 (en) 2007-07-04
IL169577A (en) 2010-06-16
EP1589023A4 (de) 2008-12-10
NO20053997L (no) 2005-10-28
HK1077070A1 (en) 2006-02-03
CN101367851A (zh) 2009-02-18
EP1589023A1 (de) 2005-10-26
CA2514931A1 (en) 2004-08-12
WO2004067542A1 (ja) 2004-08-12
NO20053997D0 (no) 2005-08-29
KR20050094465A (ko) 2005-09-27
MXPA05008190A (es) 2006-02-17
NZ541455A (en) 2007-08-31
US7632930B2 (en) 2009-12-15
TWI318202B (en) 2009-12-11
PT1589023E (pt) 2010-10-29
DE602004028799D1 (en) 2010-10-07
CN100360548C (zh) 2008-01-09

Similar Documents

Publication Publication Date Title
DK1213296T3 (da) Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf
EP1679309A4 (de) Antistress-arzneimittel und dessen medizinische verwendung
ATE372767T1 (de) Dpp-iv-hemmer
NO20054852L (no) GFAT inhibitorer
ATE532770T1 (de) Imidazolderivat
ATE358484T1 (de) Antidiabetische medikamente
EP1642880A4 (de) Proteininhibitoren der hsp90-familie
NO20053762L (no) Kondensert furanforbindelse.
EP1634874A4 (de) Imidazolidinderivate
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
CY1111271T1 (el) Παραγωγο τριαζολονης
EP1775289A4 (de) Neue imidazolidinderivate
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
DK1589023T3 (da) Oligosaccharid-derivat
NO20055695L (no) Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer
EP2045258A4 (de) 3ý-ETHYNYLCYTIDINDERIVAT
DK1209166T3 (da) Hidtil ukendte A-500 359-derivater
PT1175429E (pt) Derivados halo de 9-desoxo-9a-aza-9a-homoeritromicina a
EP1914229A4 (de) Neuartige cercosporamidderivate
EP1254907A4 (de) Pyrrolopyridazin-verbindungen
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
AU2003235359A1 (en) Biguanide derivative and therapeutic agent for diabetes containing the same
BRPI0511824A (pt) radiossensibilizador
MX2008002753A (es) Derivados de piridazinona utilizados para el tratamiento de dolor.
MY142362A (en) Pharmaceutical composition for promoting angiogenesis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1589023

Country of ref document: EP